Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1NET 1Gastrointestinal 1Endocrine 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Lung Neoplasms 4Breast Neoplasms 4Stomach Neoplasms 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Melanoma 3Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Neuroendocrine Tumors 2Mesothelioma 2Colorectal Neoplasms 2Adenocarcinoma of Lung 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Turcot syndrome 1Thyroid Neoplasms 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Pheochromocytoma 1Paraganglioma 1Neoplasms, Squamous Cell 1Neoplasms 1Microsatellite Instability 1Mesothelioma, Malignant 1Meningioma 1

Interventions

pembrolizumab 3poly ICLC 1osimertinib 1fludarabine phosphate 1fludarabine 1enzalutamide 1durvalumab 1cobimetinib 1atezolizumab 1advexin 1Taxes 1Pemetrexed 1Paclitaxel 1Nivolumab 1Injections, Subcutaneous 1Injections 1High-Intensity Focused Ultrasound Ablation 1Gemcitabine 1Cyclophosphamide 1Cisplatin 1Biological Products 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Squamous Cell × fludarabine phosphate × Thoracic × Clear all
NCT03935893 2026-06-01

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

University of Pittsburgh

Phase 2 Active not recruiting
20 enrolled
DermatologicEndocrineGastrointestinalNETOther solid neoplasmSarcomaThoracic

Turcot syndrome, Mesothelioma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Neuroendocrine Tumors, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡